[HTML][HTML] Watch and wait approach in rectal cancer: Current controversies and future directions

F López-Campos, M Martín-Martín… - World journal of …, 2020 - ncbi.nlm.nih.gov
According to the main international clinical guidelines, the recommended treatment for
locally-advanced rectal cancer is neoadjuvant chemoradiotherapy followed by surgery …

Radiomics for the prediction of treatment outcome and survival in patients with colorectal cancer: a systematic review

FCR Staal, DJ Van Der Reijd, M Taghavi… - Clinical colorectal …, 2021 - Elsevier
Prediction of outcome in patients with colorectal cancer (CRC) is challenging as a result of
lack of a robust biomarker and heterogeneity between and within tumors. The aim of this …

Artificial Intelligence in magnetic Resonance guided Radiotherapy: Medical and physical considerations on state of art and future perspectives

D Cusumano, L Boldrini, J Dhont, C Fiorino, O Green… - Physica medica, 2021 - Elsevier
Over the last years, technological innovation in Radiotherapy (RT) led to the introduction of
Magnetic Resonance-guided RT (MRgRT) systems. Due to the higher soft tissue contrast …

Deep learning radiomics-based prediction of distant metastasis in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A multicentre …

X Liu, D Zhang, Z Liu, Z Li, P Xie, K Sun, W Wei… - …, 2021 - thelancet.com
Background Accurate predictions of distant metastasis (DM) in locally advanced rectal
cancer (LARC) patients receiving neoadjuvant chemoradiotherapy (nCRT) are helpful in …

Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an …

L Boldrini, D Cusumano, G Chiloiro, C Casà… - La radiologia …, 2019 - Springer
The aim of this study was to evaluate the variation of radiomics features, defined as “delta
radiomics”, in patients undergoing neoadjuvant radiochemotherapy (RCT) for rectal cancer …

Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features

V Giannini, S Mazzetti, I Bertotto, C Chiarenza… - European journal of …, 2019 - Springer
Purpose Pathological complete response (pCR) following neoadjuvant chemoradiotherapy
or radiotherapy in locally advanced rectal cancer (LARC) is reached in approximately 15 …

[HTML][HTML] Adaptive radiotherapy enabled by MRI guidance

A Hunt, VN Hansen, U Oelfke, S Nill, S Hafeez - Clinical Oncology, 2018 - Elsevier
Adaptive radiotherapy (ART) strategies systematically monitor variations in target and
neighbouring structures to inform treatment-plan modification during radiotherapy. This is …

MRI radiomics independent of clinical baseline characteristics and neoadjuvant treatment modalities predicts response to neoadjuvant therapy in rectal cancer

M Song, S Li, H Wang, K Hu, F Wang, H Teng… - British Journal of …, 2022 - nature.com
Background To analyse the performance of multicentre pre-treatment MRI-based radiomics
(MBR) signatures combined with clinical baseline characteristics and neoadjuvant treatment …

Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development

G Chiloiro, D Cusumano, P de Franco, J Lenkowicz… - La radiologia …, 2022 - Springer
Purpose Our study investigated the contribution that the application of radiomics analysis on
post-treatment magnetic resonance imaging can add to the assessments performed by an …

Radiomics-based pretherapeutic prediction of non-response to neoadjuvant therapy in locally advanced rectal cancer

X Zhou, Y Yi, Z Liu, W Cao, B Lai, K Sun, L Li… - Annals of surgical …, 2019 - Springer
Objective The aim of this study was to investigate whether pretherapeutic, multiparametric
magnetic resonance imaging (MRI) radiomic features can be used for predicting non …